Fig. 1From: Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registrySchematic of the GLORIA-AF programGLORIA-AF, Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation; NOAC, non-VKA oral anticoagulant; VKA, vitamin K antagonistBack to article page